UnitedHealth Group Incorporated (UNH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $365.09B
Last updated: Nov 17, 2026 at 4:44 PM ET
UnitedHealth Group Incorporated (UNH) Statistics
UnitedHealth Group (UNH) has a market cap of $365.09B and an enterprise value of $413.58B. Its trailing P/E is 19.1x.
Total Valuation
Enterprise value is 13.28% above the market cap, as debt exceeds cash.
| Market Cap | $365.09B |
|---|---|
| Enterprise Value | $413.58B |
| Latest price (Nov 17, 2026) | $389.81 |
Key Dates
The next earnings report is expected on Jan 25, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 7, 2026.
| Next Earnings Date | Jan 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 13, 2026 |
| Next Ex-Dividend Date | Dec 7, 2026 |
| Next Payment Date | Dec 15, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.8x and 3.6x. Its year-end P/E ranged from 18.3x to 26.4x from 2016 to 2025.
| P/E Ratio | 19.1x |
|---|---|
| Forward P/E | 18.7x |
| P/S Ratio | 0.8x |
| Forward P/S | 0.8x |
| P/B Ratio | 3.6x |
| P/FCF Ratio | 15.3x |
| P/OCF Ratio | 13.9x |
| PEG Ratio | 1.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 14.3x EBITDA and 17.4x free cash flow.
| EV / Earnings | 24.8x |
|---|---|
| EV / Sales | 0.9x |
| EV / EBITDA | 14.3x |
| EV / EBIT | 17.5x |
| EV / FCF | 17.4x |
Price Statistics
The stock is up 22.88% over 52 weeks and trades 0.40% below its 50-day average.
| Beta (1Y) | 0.37 |
|---|---|
| 52-Week Change | +22.88% |
| 1-Month Change | -4.20% |
| 3-Month Change | +0.92% |
| 6-Month Change | +1.32% |
| 5-Year Change | -11.62% |
| 10-Year Change | +187.96% |
| Total Return (1Y) | +25.74% |
| Total Return (3Y CAGR) | -8.77% |
| Total Return (5Y CAGR) | -1.42% |
| Return vs SPY (1Y) | +14.57% |
| Max Drawdown (1Y) | -26.77% |
| Max Drawdown (3Y) | -61.39% |
| Sharpe Ratio (1Y) | 0.65 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $391.37 |
| 200-Day Average | $365.32 |
| 52-Week Range | $252.96 to $458.79 |
| RSI (14 Days) | 43.0 |
| Average Volume (20 Days) | 4.96M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.74x current liabilities, and total debt is 0.76x shareholder equity.
| Current Ratio | 0.74x |
|---|---|
| Quick Ratio | 0.74x |
| Debt / Equity | 0.76x |
| Debt / EBITDA | 2.67x |
| Debt / FCF | 3.26x |
| Interest Coverage | 6.12x |
Returns and Efficiency
Return on invested capital is 11.56% over the last 12 months, against a 5-year average of 13.96%.
| Return on Equity (ROE) | 16.99% |
|---|---|
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 11.56% |
| Return on Capital Employed (ROCE) | 11.98% |
| ROE (5Y Average) | 21.48% |
| ROA (5Y Average) | 6.89% |
| ROIC (5Y Average) | 13.96% |
| Asset Turnover | 1.43x |
| Receivables Turnover | 9.53x |
Taxes
Income tax took 15.54% of pretax income over the last 12 months.
| Income Tax (TTM) | $3.07B |
|---|---|
| Effective Tax Rate | 15.54% |
Scores
UNH has an Altman Z-Score of 3.04, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.04 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $449.66B over the last 12 months is up 3.33% from the 12 months before.
| Revenue | $449.66B |
|---|---|
| Revenue Growth (YoY) | +3.33% |
| Gross Profit | $89.21B |
| Operating Income | $23.92B |
| Pretax Income | $19.73B |
| Net Income | $16.67B |
| EBITDA | $27.85B |
| EBIT | $23.59B |
| Reported EPS (TTM) | $20.41 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 31.36% of the $312.78B in total assets.
| Cash and Equivalents | $25.84B |
|---|---|
| Total Debt | $74.33B |
| Net Debt | $48.49B |
| Net Debt Per Share | $54.05 |
| Working Capital | -$30.24B |
| Shareholder Equity | $98.10B |
| Book Value Per Share | $109.36 |
| Tangible Book Value | -$35.26B |
| Total Assets | $312.78B |
| Total Liabilities | $207.24B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $3.37B of capital spending, operating cash flow left $22.83B of free cash flow.
| Operating Cash Flow | $26.20B |
|---|---|
| Capital Expenditures | $3.37B |
| Free Cash Flow | $22.83B |
| FCF Per Share | $25.43 |
| Depreciation and Amortization | $4.26B |
| Dividends Paid | $8.17B |
| Share Repurchases | $5.20B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 5.32%, against a 5-year average of 7.62%.
| Gross Margin | 19.84% |
|---|---|
| Operating Margin | 5.32% |
| Pretax Margin | 4.39% |
| Net Margin | 3.71% |
| EBITDA Margin | 6.19% |
| EBIT Margin | 5.25% |
| FCF Margin | 5.08% |
| Gross Margin (5Y Average) | 35.82% |
| Operating Margin (5Y Average) | 7.62% |
| Net Margin (5Y Average) | 5.09% |
Growth
Revenue grew 11.35% a year over 3 years, and EPS fell 9.75% a year.
| Revenue Growth (3Y CAGR) | +11.35% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.72% |
| EPS Growth (3Y CAGR) | -9.75% |
| EPS Growth (5Y CAGR) | -0.67% |
| FCF Growth (3Y CAGR) | -11.77% |
| FCF Growth (5Y CAGR) | -4.39% |
| Operating Income Growth (3Y CAGR) | -12.63% |
Dividends and Yields
UNH pays out 31.02% of earnings as dividends.
| Dividend Per Share (Annual) | $9.28 |
|---|---|
| Dividend Yield | 2.38% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +10.90% |
| Dividend Growth (5Y CAGR) | +12.57% |
| Payout Ratio | 31.02% |
| FCF Payout Ratio | 35.80% |
| Earnings Yield | 5.24% |
| FCF Yield | 6.53% |
| Buyback Yield | 1.31% |
| Shareholder Yield | 3.65% |
Stock Splits
The last split was a 2-for-1 forward split on May 31, 2005.
| Last Split Date | May 31, 2005 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, UNH has the 7th highest P/E and the 4th highest P/S.
P/E RatioPeer median 17.0x
P/S RatioPeer median 0.4x
ROICPeer median 8.99%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.08%
Dividend YieldPeer median 0.61%
| P/E Ratio | 19.1x vs 17.0x median |
|---|---|
| P/S Ratio | 0.8x vs 0.4x median |
| ROIC | 11.56% vs 8.99% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.33% vs +8.08% median |
| Dividend Yield | 2.38% vs 0.61% median |
Analyst Forecast
Consensus estimates put revenue growth at 1.70% and EPS growth at 19.60% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +1.70% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +19.60% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About UNH
What is UNH's market cap?
UnitedHealth Group has a market cap of $365.09B. Its enterprise value, which adds debt and subtracts cash, is $413.58B.
What is UNH's P/E ratio?
UnitedHealth Group has a trailing P/E ratio of 19.1x and a forward P/E of 18.7x.
How many shares of UNH are outstanding?
UnitedHealth Group has 897.00M shares outstanding. The count is down 0.99% from a year earlier.
Does UNH pay a dividend?
Yes. UnitedHealth Group pays $9.28 a share a year, a dividend yield of 2.38%.
How much debt does UNH have?
UnitedHealth Group has $74.33B of total debt and $25.84B of cash and equivalents, a net debt position of $48.49B.
UNH pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts